The present invention is directed to novel quinolines and quniazolines, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof which are useful for the treatment of protein kinases mediated diseases and conditions. The compounds of this invention have a general Formula (I) wherein R
1
to R
11
and X are defined herein.
本发明涉及新型
喹啉和
喹唑啉、它们的衍
生物、药学上可接受的盐、溶剂和
水合物,它们可用于治疗蛋白激酶介导的疾病和病症。本发明的化合物具有通式(I),其中R1至R11和X的定义如下。